NVAX241227P17000
- 9.17
- 0.000.00%
Novavax Newsroom
Novavax Inc. Stock Underperforms Tuesday When Compared To Competitors
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Peering Into Novavax's Recent Short Interest
B.Riley Financial Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $22
Novavax's Strategic Partnerships and Pipeline Developments Drive Buy Rating With Promising Long-term Growth Potential
Novavax Says Australia Cancels Delivery of Some Covid-19 Doses
Express News | Novavax- Agreed to Updated Delivery Schedule for Potential Delivery of Covid-19 Vaccine/Future Variant Covid-19 Vaccine Through End of 2029
Express News | Novavax- Acknowledged Commonwealth Cancellation of Delivering Certain Doses of Co’s Covid-19 Vaccine Scheduled for Delivery Between Q4 2023 & Q4 2025
Express News | Novavax Inc - on Dec 12, Entered Amendment 5 to Advanced Purchase Agreement With Commonwealth of Australia
Express News | CA Governor Newsom Proclaimed State Of Emergency To Further Enhance State's Preparedness And Accelerate The Bird Flu Cross-Agency Response Efforts
Express News | CDC Confirms First Severe Case Of H5N1 Bird Flu In U.S. On December 13; Patient Hospitalized With Severe Case Of Avian Influenza A Virus Infection In Louisiana
Novavax, Inc.'s (NASDAQ:NVAX) Shares Bounce 26% But Its Business Still Trails The Industry
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone
Why Is Novavax (NVAX) Up 13.6% Since Last Earnings Report?
Institutional Investors Control 53% of Novavax, Inc. (NASDAQ:NVAX) and Were Rewarded Last Week After Stock Increased 6.3%
Novavax Analyst Ratings
H.C. Wainwright Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $19
Jim Cramer Is 'Not A Fan' Of Novavax, Says This Tech Stock Is 'Expensive'
Novavax, Inc. (NVAX) Is Attracting Investor Attention: Here Is What You Should Know
Express News | Novavax Inc - Working With FDA on Potential Accelerated Approval